Status:
RECRUITING
HER2-positive Breast Cancer Registry
Lead Sponsor:
Priyanka Sharma
Conditions:
HER2 + Breast Cancer
Eligibility:
All Genders
18+ years
Brief Summary
The goal of this observational study is to better understand links between patient or tumor characteristics and outcomes in HER2-positive breast cancer.
Eligibility Criteria
Inclusion
- Stage I-IV HER2-positive breast cancer
Exclusion
- None
Key Trial Info
Start Date :
September 27 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 1 2044
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT06603597
Start Date
September 27 2024
End Date
October 1 2044
Last Update
September 10 2025
Active Locations (6)
Enter a location and click search to find clinical trials sorted by distance.
1
KUCC - Indian Creek
Overland Park, Kansas, United States, 66211
2
KUCC - Overland Park
Overland Park, Kansas, United States, 66215
3
KUCC - Briarcliff
Westwood, Kansas, United States, 66205
4
KUCC - Olathe
Westwood, Kansas, United States, 66205